See what we’re reading this week at Global Biodefense on topics including the new White House biosecurity plan, recommendations of the Blue Ribbon Study Panel on Biodefense, bubonic plague in Oregon, flu vaccine in pill form and more…
BIODEFENSE & BIOSECURITY POLICY
- US panel proposes executive biodefence office (Nature)
- White House releases detailed lab biosafety plan (CIDRAP)
- Threat Level Unknown – Joseph Lieberman and Tom Ridge (Philadelphia Inquirer)
- Report: Put Biden in charge of biodefense (Science)
- U.S. high-containment biosafety labs to get closer scrutiny (Science)
- Living Dangerously: Biodefense vs. biorisks (CBRNe Portal)
MEDICAL COUNTERMEASURES
- Towards a safe and efficient SARS-coronavirus vaccine (MNT)
- BARDA backs development of flu vaccine tablet (Global Biodefense)
- What next for the malaria RTS,S vaccine candidate? (The Lancet)
- Prophylactic platelet transfusion ineffective in dengue patients (Healio)
- Bacterial hole puncher could be new broad-spectrum antibiotic (MNT)
LESSONS LEARNED
- Ebola ‘Team B’ model could serve more broadly, its members say (CIDRAP)
- MERS, Ebola, bird flu: Science’s big missed opportunities (Reuters)
- Ebola: missed opportunities for Europe–Africa research (The Lancet)
- Indirect costs associated with deaths from the Ebola virus disease in West Africa (IDP)
IMMUNIZATIONS
- Why spacing out the vaccine schedule is not the answer (Brookings)
- Apps for immunization: Leveraging mobile devices (HV&I)
OUTBREAK NEWS & THREAT SURVEILLANCE
- Nearly 200 sickened by Shigella outbreak in San Francisco (Reuters)
- UK finds isolated case of anthrax in a cow in southwest England (Reuters)
- Teenage girl in Oregon hospitalized with bubonic plague (Reuters)
- Deadly bird flu flying south for winter (GSN)
